Results 261 to 270 of about 179,393 (307)

Engineering Oncolytic Virus‐Armed Macrophages for Enhanced Cancer Immunotherapy

Advanced Science, EarlyView.
ZIFOA‐M is engineered by conjugating oncolytic adenovirus‐loaded ZIF‐8 nanoparticles onto macrophage surfaces via bioorthogonal chemistry. Upon tumor infiltration, the platform releases OA to downregulate CD47/CD24 on tumor cells, restoring macrophage phagocytosis.
Jilong Wang, Ning Lu, Zhuo Yan, Luyi Ye, Luyao Bai, Shanshan Yuan, Yuting Zhu, Yiru Xiong, Yongheng Bai, Yaping Chen, Junjie Deng   +10 more
wiley   +1 more source

I do what I want: are our patients adhering to bracing recommendations? Early results of a prospective cohort study. [PDF]

Spine Deform
Regan MD, Li Y, Hogue GD, Johnson ME, Anari JB, Neal KM, Baldwin KD.   +6 more
europepmc   +1 more source

Impact of socioeconomic status on tumor stage, molecular subtype distribution, treatment adherence, and survival outcomes in breast cancer. [PDF]

Front Oncol
Li T, Liu H, Ma S, Guo L, Li J.
europepmc   +1 more source

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety. [PDF]

Ther Adv Gastroenterol
Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S.   +2 more
europepmc   +1 more source

Factors Influencing Adherence to All-Oral Short-Course Treatment for DR-TB and Establishment of a Predictive Model. [PDF]

Infect Drug Resist
Huang J, Zhu QD, Li ZF, Xie K, Deng JN, Ma QY, Su HZ, Lu TT, Lu XF, Hu YL, Xie ZH.   +10 more
europepmc   +1 more source

Analysis of key obstacles affecting long-term inhalation therapy compliance in children with bronchial asthma at primary hospitals. [PDF]

Front Pediatr
Fan D, Wu Y, Shi W.
europepmc   +1 more source

Attitudes, Beliefs and Perceptions of Medication Prescribing for Older First Nations Peoples: A Scoping Review. [PDF]

Australas J Ageing
Franks N, McDermott K, Carlisle K, Russell S, Wallace V, Strivens E.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Compliance, adherence, and the treatment of multiple sclerosis

Journal of Neurology, 2008
With the availability of disease-modifying, immunomodulatory therapies (DMT) for multiple sclerosis (MS) and the first long-term studies, it became obvious that problems of compliance to complex treatment regimens under chronic conditions would also apply to these approaches.
Uwe K Zettl, Zettl Uwe K
exaly   +3 more sources

Ethical issues of compliance/adherence in the treatment of hypertension

Advances in Chronic Kidney Disease, 2004
The ethics of compliance suggests a conflict within the definition of compliance. Evidence-based medicine appears to provide clear pathways for clinical decisions, but, usually, the patient is not a part of the decision-making process. Physicians often develop a treatment plan and then attempt to make the therapy acceptable to the patient to achieve ...
Judith Bernardini
exaly   +3 more sources

A Three-Stage Model of Treatment Continuity: Compliance, Adherence, and Maintenance

2020
Models of health behavior have shifted significantly in the last few decades to viewing the patient as an active, discriminating participant in health care procedures rather than as a passive recipient of the healing process. One of the forces behind this change has been a growing recognition in medicine that many acute medical crises can be averted by
Jean L. Kristeller, Judith Rodin
openaire   +1 more source